Synbio International Inc. Announces New Chief Financial Officer
Synbio International Inc. (OTC: SYIN) is thrilled to announce the appointment of Desiree Cain, CPA, MBA, as its new Chief Financial Officer and member of the Board of Directors. This strategic move highlights the company's dedication to fortifying its governance and advancing its financial strategies, all aimed at propelling the company into its next growth phase.
A Seasoned Financial Expert Joins the Team
With over 25 years of profound experience in corporate finance and accounting, Ms. Cain brings a wealth of knowledge to Synbio. As a licensed CPA in New York and holder of an MBA in Strategic Management, her expertise promises to enhance the financial infrastructure of the organization. Her past achievements include optimizing operations and driving value for shareholders, showcasing her capability to lead Synbio through its evolving challenges.
Financial Oversight and Governance
In her new role, Ms. Cain will manage all financial operations within Synbio, which encompass accounting, reporting, and adherence to the requirements set forth by the U.S. SEC and OTC Markets. Her leadership will be pivotal in shaping governance and risk management frameworks that align with best practices, guaranteeing transparency and operational efficiency across the board.
Leadership's Enthusiasm for the Appointment
Claudio Solitario, the CEO of Synbio International Inc., expressed his excitement for this new chapter. He stated, "We are delighted to welcome Desiree to Synbio's leadership team. Her extensive financial expertise will significantly enhance our corporate governance and sharpen our strategies for capital raising, providing the strategic insight essentials as we embark on our next growth phase. I am thrilled to welcome her on board."
Focus on Innovation in Medical Diagnostics
Located at the forefront of advancing clinically validated AI-driven medical diagnostics, Synbio aims to close the gap between wellness and medicine. With strategic partnerships and ongoing research collaborations, the company is dedicated to creating science-based solutions that elevate the quality of life while empowering healthcare providers to deliver superior patient care.
About Synbio International Inc.
Synbio International Inc. (OTC: SYIN) is committed to revolutionizing the medical diagnostics field with innovative technologies. Their focus on AI-driven solutions not only seeks to provide accurate diagnostics but also to develop collaborative strategies that integrate wellness practices into everyday healthcare. The company's initiatives are set to pave the way for transformative changes in how healthcare services are delivered and managed.
For media inquiries, please contact:
Synbio International Inc.
info@synbiointl.com
(646) 359-4854
www.synbiointl.com
Frequently Asked Questions
Who is the new Chief Financial Officer of Synbio International?
The new Chief Financial Officer is Ms. Desiree Cain, a skilled professional with extensive experience in corporate finance.
What qualifies Ms. Desiree Cain for the CFO position?
Ms. Cain is a licensed CPA with an MBA in Strategic Management and over 25 years of experience in the financial sector.
What is Synbio International Inc.'s focus?
Synbio focuses on clinically validated AI-driven medical diagnostics, aiming to enhance wellness and medical outcomes.
What are the goals of the company with this leadership change?
The goal is to strengthen corporate governance, optimize financial strategies, and support the future growth of the company.
Where can I find more information about Synbio International Inc.?
More information can be found on their official website at www.synbiointl.com.
